IL290961A - System and method of multi-drug delivery - Google Patents

System and method of multi-drug delivery

Info

Publication number
IL290961A
IL290961A IL290961A IL29096122A IL290961A IL 290961 A IL290961 A IL 290961A IL 290961 A IL290961 A IL 290961A IL 29096122 A IL29096122 A IL 29096122A IL 290961 A IL290961 A IL 290961A
Authority
IL
Israel
Prior art keywords
drug delivery
drug
delivery
Prior art date
Application number
IL290961A
Other languages
Hebrew (he)
Inventor
Yihong Qiu
Deliang Zhou
Mohamad Shebley
Juki Wing-Keung Ng
Ahmed Mohamed
Jian-Hwa Han
David Metzger
Alexander RUGGLES
hui Zu
Xi Shao
Yuchuan Gong
Yisheng Chen
Jian Gong
Min Li
Original Assignee
Abbvie Inc
Yihong Qiu
Deliang Zhou
Mohamad Shebley
Ng Juki Wing Keung
Ahmed Mohamed
Han Jian Hwa
David Metzger
Alexander RUGGLES
hui Zu
Xi Shao
Yuchuan Gong
Yisheng Chen
Jian Gong
Min Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc, Yihong Qiu, Deliang Zhou, Mohamad Shebley, Ng Juki Wing Keung, Ahmed Mohamed, Han Jian Hwa, David Metzger, Alexander RUGGLES, hui Zu, Xi Shao, Yuchuan Gong, Yisheng Chen, Jian Gong, Min Li filed Critical Abbvie Inc
Publication of IL290961A publication Critical patent/IL290961A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074Filling capsules; Related operations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL290961A 2019-08-29 2022-02-27 System and method of multi-drug delivery IL290961A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962893567P 2019-08-29 2019-08-29
US201962893573P 2019-08-29 2019-08-29
US202062981180P 2020-02-25 2020-02-25
US202063022823P 2020-05-11 2020-05-11
PCT/US2020/048107 WO2021041608A1 (en) 2019-08-29 2020-08-27 System and method of multi-drug delivery

Publications (1)

Publication Number Publication Date
IL290961A true IL290961A (en) 2022-04-01

Family

ID=74683538

Family Applications (1)

Application Number Title Priority Date Filing Date
IL290961A IL290961A (en) 2019-08-29 2022-02-27 System and method of multi-drug delivery

Country Status (9)

Country Link
EP (1) EP4021420A4 (en)
JP (1) JP2022546496A (en)
CN (1) CN114650810A (en)
AU (1) AU2020336093A1 (en)
BR (1) BR112022003895A2 (en)
CA (1) CA3152734A1 (en)
IL (1) IL290961A (en)
MX (1) MX2022002526A (en)
WO (1) WO2021041608A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115989023A (en) * 2020-08-25 2023-04-18 艾伯维公司 System and method for multiple drug delivery
US11273128B1 (en) * 2021-04-15 2022-03-15 Sandoz Ag Elagolix formulation
CN116648239A (en) * 2021-08-26 2023-08-25 宁德时代新能源科技股份有限公司 Liquid bag, battery monomer, battery and electricity utilization device
CN113876728B (en) * 2021-11-17 2022-12-13 南京唯创远医药科技有限公司 Oxagolide freeze-dried tablet and preparation method thereof
EP4279075B1 (en) * 2022-05-12 2024-07-10 Zaklady Farmaceutyczne Polpharma S.A. A pharmaceutical composition comprising elagolix

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
US20080075772A1 (en) * 2006-04-13 2008-03-27 Lawrence Solomon Pharmaceutical compositions having novel scoring patterns and methods of using those compositions
WO2010014502A1 (en) * 2008-07-31 2010-02-04 Aptapharma, Inc. Functionally coated breakable tablets
KR101861307B1 (en) * 2011-10-13 2018-07-06 한미약품 주식회사 Composite formulation comprising a tablet encapsulated in a hard capsule
EP3384930A1 (en) * 2013-03-15 2018-10-10 AbbVie Inc. Compositions for use in treating heavy menstrual bleeding
US9456987B2 (en) * 2013-04-03 2016-10-04 Binutra, Inc. Capsule with internal diaphragm
AU2017316583A1 (en) * 2016-08-23 2019-03-28 Mylan Inc. Child resistant medication packaging
TW201912157A (en) * 2017-08-18 2019-04-01 美商艾伯維有限公司 Solid pharmaceutical formulation for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome and adenomyosis

Also Published As

Publication number Publication date
EP4021420A1 (en) 2022-07-06
WO2021041608A1 (en) 2021-03-04
CA3152734A1 (en) 2021-03-04
BR112022003895A2 (en) 2022-05-24
MX2022002526A (en) 2022-06-23
JP2022546496A (en) 2022-11-04
CN114650810A (en) 2022-06-21
EP4021420A4 (en) 2023-11-22
AU2020336093A1 (en) 2022-03-31

Similar Documents

Publication Publication Date Title
IL290961A (en) System and method of multi-drug delivery
IL264677B (en) System and method for continuous testing and delivery of software
EP3384125A4 (en) Method and apparatus for elevating the tapered stress joint or flex joint of an scr above the water
EP3666849A4 (en) Diverting agent and method using same for filling crack of winze
EP3838804A4 (en) Delivery site and delivery method
EP3820403A4 (en) Implant delivery system and method
EP3820411A4 (en) Implant delivery system and method of use
GB2596770B (en) Carrier-resolved photo-hall system and method
GB201906418D0 (en) Conveyor system and method
SG11202103826SA (en) Method of secure communication and system thereof
GB2573856B (en) Dispenser system and method of use
IL284565A (en) Transdermal system for the delivery of abaloparatide and method of use
SG10202010783RA (en) Restoration coating system and method
EP3908708A4 (en) Bioretentional system and method of construction thereof
GB2600580B (en) System and method for preparing MRNA
GB202115550D0 (en) System and method for management of substances
GB2590126B (en) Navigation system and method
SG11202108415YA (en) Direct extended reach system and method
EP4062126C0 (en) Navigation system and method
EP3805067A4 (en) Yunitsky transport system and method of construction thereof
GB201914948D0 (en) System and method of aerosol delivery
GB201914952D0 (en) System and method of aerosol delivery
GB2602592B (en) Design system and design method
GB201900467D0 (en) Dispenser system and method of use
EP3861356A4 (en) System and method of fluid delivery